Medicine and Healthcare | Media Room | Newswire

Mountain Land Physical Therapy ("Mountain Land") Partners with OccuPro to Expand Employer-Focused Rehab Services

Thu, 17 Sep 2026 15:40:00 +0000

Partnership strengthens workers' compensation physical therapy, industrial rehabilitation, FCE, and return-to-work programs across Utah, Idaho, and Montana

Infinx Earns No. 1 Ranking for Provider-Side Prior Authorization Automation and PAIR Readiness

Thu, 17 Sep 2026 14:20:00 +0000

Black Book Research's 2026 hospital RCM rankings place Infinx first in a client-rated category focused on prior authorization automation

Sacred Connection Introduces Ancestral Amazonian Protocol for Chronic Sinus Pressure and Tension Headaches

Thu, 17 Sep 2026 14:00:00 +0000

Offering a natural, plant-based alternative to chemical decongestants and pain relievers, Sacred Connection brings direct-trade botanical preparations to those seeking rapid head and sinus relief.

American Medical Administrators, Inc. Appoints Mark D. Goldberg, MD, as Chief Medical Officer

Wed, 16 Sep 2026 12:00:00 +0000

Veteran Physician Leader to Advance Clinical Strategy, Physician Engagement and Value-Based Care Initiatives

Sacred Connection Partners with Non-Profit Conexão Ancestral to Fight Botanical Exploitation and Fund Vital Amazonian Indigenous Projects

Tue, 15 Sep 2026 14:00:00 +0000

Combining radical supply-chain transparency with direct non-profit action, Sacred Connection funds clean water infrastructure, cultural preservation, and land stewardship across Huni Kuin, Yawanawá, and Katukina villages.

Clinical Trial of the Oral Drug NV-387 to Treat Ebola to Start Next Week, Hoping to Reduce Fatalities and Spread, As the Largest Ebola Outbreak is Expanding in  DR Congo with 48% Crude Fatality Rate, Says NanoViricides

Tue, 15 Sep 2026 13:25:00 +0000

Jaguar Health, Inc. Announces Reverse Stock Split

Tue, 15 Sep 2026 13:00:00 +0000

Reverse split approved at April 2026 Special Meeting of Stockholders

Shares of Jaguar Health common stock to begin trading on split-adjusted basis on September 17, 2026

Lobe Sciences to Present Low-Dose L-130 Clinical Data at 9th Neuropsychiatric Drug Development Summit

Tue, 15 Sep 2026 03:00:00 +0000

● Dr. Frederick D. Sancilio to present "Reimagining Psychedelic Therapeutics for Daily Outpatient Use: Advancing Low-Dose Psilocin Beyond the Hallucinogenic Paradigm" on Wednesday, September 16

● Presentation covers Phase 1a first-in-human results for Conjugated Psilocin™ (L-130), including oral bioavailability, dose consistency and the absence of hallucinogenic effects at low doses

● Lobe to exhibit throughout the summit, September 15-17, alongside senior discovery, clinical and business development leaders from major pharmaceutical companies

Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update

Fri, 11 Sep 2026 13:00:00 +0000

Advances GelrinC^® U.S. pivotal trial with 43 patients treated; Completion of enrollment expected by approximately year end 2026

Expands European commercialization readiness, including surgeon training and regulatory approval of new manufacturing process that improves production yield 400%

Strengthened balance sheet with $6.5 million private placement in June 2026

Ahead of 9/11, U.S. Veterans' Non-Profit Partners with World's Only Medically Licensed Ayahuasca Facility to Combat PTSD and Suicide

Thu, 10 Sep 2026 17:27:00 +0000

This private, veteran-only retreat will offer medically supervised plant medicine treatment and long-term integration support for veterans living with treatment-resistant PTSD

Sacred Connection Launches Direct-Trade Amazonian Grounding Botanicals in the U.S. to Combat Modern Digital Burnout

Thu, 10 Sep 2026 14:00:00 +0000

Bridging ancestral Amazonian wisdom with modern somatic wellness, Sacred Connection introduces ethically sourced Hapé blends designed to reset overstimulated minds in 60 seconds.

Surmodics Opens Medical Device Coating Capabilities in Ireland

Thu, 10 Sep 2026 14:00:00 +0000

The Galway Facility Brings Nearly 50 Years of Coating Expertise, Cleanroom Coating Services and Analytical Testing Closer to Medical Device Manufacturers Across Ireland and Europe

The Longevity Centers of America Opens Central Florida Location in Orlando's Dr. Phillips Corridor

Thu, 10 Sep 2026 14:00:00 +0000

The physician-led longevity and regenerative medicine practice is opening its first clinic in the Orlando area and is now accepting patients for the waitlist ahead of its September 28 opening.

All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)

Thu, 10 Sep 2026 13:00:00 +0000

Continuation of treatment with blinded doses of crofelemer in the extension phase of the trial will support company's plans to file an NDA in mid-2027 for MVID, an ultrarare pediatric disease

Transition of Fitzgibbon Hospital Operations Complete; American Medical Administrators Begins Management of Hospital and Related Healthcare Operations

Wed, 09 Sep 2026 22:55:00 +0000

Hospital, Skilled Nursing Facility and Rural Health Clinics Remain Open and Continue Serving the Community

Alpha Genesis Launches AGI Ventures with an Initial $50 Million Commitment to Emerging Biotechnology Companies

Wed, 09 Sep 2026 13:00:00 +0000

New venture-development division pairs strategic investment with the scientific expertise and preclinical research infrastructure of Alpha Genesis

Sacred Connection Unveils Ancestral Flow-State Priming Tool for the Biohacking and Performance Community

Tue, 08 Sep 2026 14:00:00 +0000

Designed for precision state control and rapid vagal activation, Sacred Connection brings direct-trade Amazonian botanical preparations to peak-performance protocols.

Now Available on Amazon: Neonorm Dog, Jaguar Health's Non-Prescription Product for Support of Normal Stool Consistency and GI Fluid Balance in Dogs

Tue, 08 Sep 2026 13:00:00 +0000

Neonorm^® Dog extends Jaguar's existing Neonorm product franchise beyond foals and calves to provide dog owners with access to a plant-based product designed to support normal stool consistency and GI fluid balance in dogs

Jaguar expects Neonorm Dog to be available through other select online and animal health retail channels shortly, including Chewy

Clinical Trial for an Oral Drug to Treat Ebola is Registered in the Pan African Clinical Trials Database and is Ready to Go, As the Largest Ebola Outbreak Continues to Expand in DR Congo

Tue, 08 Sep 2026 12:30:00 +0000

On Labor Day, Guardian Angel AI Turns Attention to America's $1 Trillion Unpaid Workforce: Family Caregivers

Mon, 07 Sep 2026 09:00:00 +0000

As millions of Americans spend the holiday caring for aging parents and loved ones, Guardian Angel AI is building technology designed to make aging at home safer - and caregiving less consuming.

Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF)

Fri, 04 Sep 2026 12:30:00 +0000

Jaguar remains sharply focused on its ongoing global development program for oral crofelemer as adjunctive therapy to parenteral support (PS) for pediatric and adult rare IF diseases, including microvillus inclusion disease (MVID)

Company plans to file NDA for crofelemer for MVID in mid-2027 to obtain FDA approval

SunTech Medical Launches Dedicated Veterinary Website, SunTechVet.com

Wed, 02 Sep 2026 16:05:00 +0000

The new platform showcases animal-specific monitoring technology designed for real-world veterinary care.

Maria Regina Rehabilitation and Nursing Earns CMS Overall Five-Star Quality Rating

Wed, 02 Sep 2026 16:00:00 +0000

CMS's highest overall rating recognizes Maria Regina Rehabilitation and Nursing for its commitment to quality, compassionate care, and positive resident outcomes.

HealthJoy Partners with Vālenz Health(R) to Connect Employees to Lower-Cost Procedures and Cancer Care

Wed, 02 Sep 2026 13:00:00 +0000

Bundled Valenz solutions for surgeries, imaging, specialty infusions, and catastrophic care now fully integrated into HealthJoy's Benefits Operating System to drive additional 50%+ savings

SpendMend Names Rob Proctor Chief Commercial Officer

Tue, 01 Sep 2026 13:30:00 +0000

Vituity Launches MVMNT to Move Longevity Medicine From Conversation to Clinical Practice

Tue, 01 Sep 2026 13:00:00 +0000

Inaugural summit brings clinicians and innovators together with evidence-based frameworks for integrating longevity medicine into practice today

Coastal Vision Medical Group Leads Orange County in Experience with TECNIS PureSee(TM) IOL

Mon, 31 Aug 2026 23:45:00 +0000

Dr. Dan B. Tran and Coastal Vision Recognized as Orange County Leaders in Advanced Cataract Lens Technology

Lobe Sciences Ltd. Announces Closing of Upsize to Non-Brokered Private Placement

Mon, 31 Aug 2026 23:00:00 +0000

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

While Measles Cases Continue to Increase in The USA and Globally, NanoViricides is Getting Ready for Clinical Trials of Its Revolutionary Broad-spectrum Drug Candidate NV-387 as A Treatment for Measles

Mon, 31 Aug 2026 12:30:00 +0000

Lobe Sciences Ltd. Announces Upsize to Non-Brokered Private Placement

Fri, 28 Aug 2026 23:00:00 +0000

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.

Lobe Sciences Expands Leadership Team with New CFO Appointment

Fri, 28 Aug 2026 12:00:00 +0000

Dr. David Kideckel, PhD, MBA, joins as Chief Financial Officer, bringing nearly two decades of life sciences, capital markets and corporate advisory experience
Current CFO, Mirza Rahimani, transitions to Vice President of Finance, providing continuity across financial reporting and operations
Appointment strengthens Lobe's leadership team as the Company advances L-130, its differentiated conjugated psilocin therapeutic being developed at sub-hallucinogenic doses for chronic cluster headache

Commercial Launch Initiated for Neonorm Dog, Jaguar Health's Non-Prescription Product for Support of Normal Stool Consistency and GI Fluid Balance in Dogs

Wed, 26 Aug 2026 13:00:00 +0000

Jaguar expects to make Neonorm Dog available through both Amazon and Chewy soon

Boston Center for Plastic Surgery and Northeast Hair Restoration Welcome Facial Plastic Surgeon Dr. Ashley Lonergan

Tue, 25 Aug 2026 12:00:00 +0000

Dual specialist in facial rejuvenation and hair transplantation brings integrated approach to patients seeking comprehensive results above the shoulders

Vibrant Wellness Brings the Most Comprehensive Gut Health Test to New York

Tue, 25 Aug 2026 04:00:00 +0000

New York State Availability for Gut Zoomer Expands Access to Comprehensive, Multi-Domain Gut Health Testing for Patients With a New York Shipping Address

CMS 2027 Proposed Rule: Key Changes to RPM, RTM and Medicare Care Management

Mon, 24 Aug 2026 19:00:00 +0000

CMS's proposed CY 2027 rule (CMS-1848-P) would reshape RPM and RTM staffing, billing, and eligibility rules. Comment period open through Sept. 14, 2026.

Dr. Dan B. Tran First in Southern California to Implant Clareon(R) TruPlus BLF IOL

Mon, 24 Aug 2026 17:30:00 +0000

Coastal Vision Medical Group Founder Among First Surgeons to Implant Alcon's Newly Launched Clareon TruPlus IOL

Dr. Vinson Eugene Allen Provided Critical Guidance as Actor Ernest Harden Jr. Faced a Medical Emergency While Filming The Pitt

Thu, 20 Aug 2026 22:25:00 +0000

Beloved Actor Ernest Harden Jr. is Grateful, Healthy and Excited to Get Back to Work

Lobe Sciences Ltd. Announces Closing of Non-Brokered Private Placement

Thu, 20 Aug 2026 12:00:00 +0000

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.

Jaguar Health Reports Second Quarter 2026 Financials

Wed, 19 Aug 2026 20:00:00 +0000

Company remains sharply focused on its ongoing global development program for crofelemer for rare intestinal failure (IF) diseases; as announced, presentation at ESPGHAN 2026 described additional groundbreaking results of evaluation of crofelemer as adjunctive oral therapy for the treatment of pediatric IF, which demonstrate reduction of parenteral support normalized to body weight of up to 48% in patient with the ultrarare microvillus inclusion disease (MVID); company expects clinical package for NDA for MVID to be ready by end of 2026, allowing submission of NDA in Q2 2027

REMINDER: Jaguar to host investor webcast Wednesday, August 19 at 4:30 p.m. Eastern regarding Q2 2026 financials and company updates (click here to register)

Infinx Builds and Scales Workflow-Integrated AI and Agentic Automation on AWS for Healthcare Revenue Cycle

Wed, 19 Aug 2026 02:05:00 +0000

Infinx expands AWS use to support its Revenue Cycle Agent Platform, enabling workflow-integrated AI, automation, and Document Capture Plus.

Jaguar Health to Hold Investor Webcast August 19 Regarding Q2 2026 Financials & Corporate Updates

Tue, 18 Aug 2026 13:00:00 +0000

Company plans to file its Earnings Report on August 19, 2026 on Form 10-Q for the quarter ended June 30, 2026

The Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo to Fight the Current Largest Ever and Expanding Ebola Outbreak to Begin Soon

Tue, 18 Aug 2026 12:30:00 +0000

Lobe Sciences Reports Third Quarter 2026 Financial Results

Tue, 18 Aug 2026 12:00:00 +0000

Imagene AI Joins Proscia Ready Partner Alliance to Advance AI-Powered IHC Companion Diagnostics Development

Tue, 18 Aug 2026 12:00:00 +0000

Integration with Proscia's Concentriq platform will facilitate pharma companies, diagnostic assay and platform providers, and CROs in operationalizing companion diagnostic programs

Vive Concierge Co-Founder Dwayne Hall's Health Equity Work Advances in Sweeping 2026 Senate Bill

Mon, 17 Aug 2026 16:00:00 +0000

Core protections from the Equal Health Care for All Act, which Hall helped conceptualize and advance, are incorporated into the Health Equity and Accountability Act of 2026

Brookside Multicare Nursing Center Earns CMS 5-Star Overall Quality Rating

Thu, 13 Aug 2026 16:30:00 +0000

Brookside Multicare Nursing Center receives the highest overall rating from the Centers for Medicare & Medicaid Services, recognizing excellence in resident care, staffing, and quality measures.

Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference August 19th

Thu, 13 Aug 2026 12:15:00 +0000

Toll Brothers Donates $1.6 Million to Help HomeAid Build a Future Without Homelessness

Wed, 12 Aug 2026 14:00:00 +0000

HomeAid is building a future without homelessness

Lobe Sciences Ltd. Announces Non-Brokered Private Placement

Wed, 12 Aug 2026 12:45:00 +0000

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.

Levita Magnetics Brings MARS(R) Magnetic Surgery Platform to Florida for the First Time

Wed, 12 Aug 2026 10:00:00 +0000

Milestone bariatric procedures at a Miami hospital mark the Florida debut of MARS®, a less invasive approach that reduces incisions, scarring, and recovery time.

Medicine and Healthcare | Media Room | Newswire

Mountain Land Physical Therapy ("Mountain Land") Partners with OccuPro to Expand Employer-Focused Rehab Services

Infinx Earns No. 1 Ranking for Provider-Side Prior Authorization Automation and PAIR Readiness

Sacred Connection Introduces Ancestral Amazonian Protocol for Chronic Sinus Pressure and Tension Headaches

American Medical Administrators, Inc. Appoints Mark D. Goldberg, MD, as Chief Medical Officer

Sacred Connection Partners with Non-Profit Conexão Ancestral to Fight Botanical Exploitation and Fund Vital Amazonian Indigenous Projects

Clinical Trial of the Oral Drug NV-387 to Treat Ebola to Start Next Week, Hoping to Reduce Fatalities and Spread, As the Largest Ebola Outbreak is Expanding in DR Congo with 48% Crude Fatality Rate, Says NanoViricides

Jaguar Health, Inc. Announces Reverse Stock Split

Lobe Sciences to Present Low-Dose L-130 Clinical Data at 9th Neuropsychiatric Drug Development Summit

Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update

Ahead of 9/11, U.S. Veterans' Non-Profit Partners with World's Only Medically Licensed Ayahuasca Facility to Combat PTSD and Suicide

Sacred Connection Launches Direct-Trade Amazonian Grounding Botanicals in the U.S. to Combat Modern Digital Burnout

Surmodics Opens Medical Device Coating Capabilities in Ireland

The Longevity Centers of America Opens Central Florida Location in Orlando's Dr. Phillips Corridor

All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)

Transition of Fitzgibbon Hospital Operations Complete; American Medical Administrators Begins Management of Hospital and Related Healthcare Operations

Alpha Genesis Launches AGI Ventures with an Initial $50 Million Commitment to Emerging Biotechnology Companies

Sacred Connection Unveils Ancestral Flow-State Priming Tool for the Biohacking and Performance Community

Now Available on Amazon: Neonorm Dog, Jaguar Health's Non-Prescription Product for Support of Normal Stool Consistency and GI Fluid Balance in Dogs

Clinical Trial for an Oral Drug to Treat Ebola is Registered in the Pan African Clinical Trials Database and is Ready to Go, As the Largest Ebola Outbreak Continues to Expand in DR Congo

On Labor Day, Guardian Angel AI Turns Attention to America's $1 Trillion Unpaid Workforce: Family Caregivers

Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF)

SunTech Medical Launches Dedicated Veterinary Website, SunTechVet.com

Maria Regina Rehabilitation and Nursing Earns CMS Overall Five-Star Quality Rating

HealthJoy Partners with Vālenz Health(R) to Connect Employees to Lower-Cost Procedures and Cancer Care

SpendMend Names Rob Proctor Chief Commercial Officer

Vituity Launches MVMNT to Move Longevity Medicine From Conversation to Clinical Practice

Coastal Vision Medical Group Leads Orange County in Experience with TECNIS PureSee(TM) IOL

Lobe Sciences Ltd. Announces Closing of Upsize to Non-Brokered Private Placement

While Measles Cases Continue to Increase in The USA and Globally, NanoViricides is Getting Ready for Clinical Trials of Its Revolutionary Broad-spectrum Drug Candidate NV-387 as A Treatment for Measles

Lobe Sciences Ltd. Announces Upsize to Non-Brokered Private Placement

Lobe Sciences Expands Leadership Team with New CFO Appointment

Commercial Launch Initiated for Neonorm Dog, Jaguar Health's Non-Prescription Product for Support of Normal Stool Consistency and GI Fluid Balance in Dogs

Boston Center for Plastic Surgery and Northeast Hair Restoration Welcome Facial Plastic Surgeon Dr. Ashley Lonergan

Vibrant Wellness Brings the Most Comprehensive Gut Health Test to New York

CMS 2027 Proposed Rule: Key Changes to RPM, RTM and Medicare Care Management

Dr. Dan B. Tran First in Southern California to Implant Clareon(R) TruPlus BLF IOL

Dr. Vinson Eugene Allen Provided Critical Guidance as Actor Ernest Harden Jr. Faced a Medical Emergency While Filming The Pitt

Lobe Sciences Ltd. Announces Closing of Non-Brokered Private Placement

Jaguar Health Reports Second Quarter 2026 Financials

Infinx Builds and Scales Workflow-Integrated AI and Agentic Automation on AWS for Healthcare Revenue Cycle

Jaguar Health to Hold Investor Webcast August 19 Regarding Q2 2026 Financials & Corporate Updates

The Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo to Fight the Current Largest Ever and Expanding Ebola Outbreak to Begin Soon

Lobe Sciences Reports Third Quarter 2026 Financial Results

Imagene AI Joins Proscia Ready Partner Alliance to Advance AI-Powered IHC Companion Diagnostics Development

Vive Concierge Co-Founder Dwayne Hall's Health Equity Work Advances in Sweeping 2026 Senate Bill

Brookside Multicare Nursing Center Earns CMS 5-Star Overall Quality Rating

Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference August 19th

Toll Brothers Donates $1.6 Million to Help HomeAid Build a Future Without Homelessness

Lobe Sciences Ltd. Announces Non-Brokered Private Placement

Levita Magnetics Brings MARS(R) Magnetic Surgery Platform to Florida for the First Time

Clinical Trial of the Oral Drug NV-387 to Treat Ebola to Start Next Week, Hoping to Reduce Fatalities and Spread, As the Largest Ebola Outbreak is Expanding in  DR Congo with 48% Crude Fatality Rate, Says NanoViricides